France· FR:63878513
MIRCERA 50 microgrammes/0,3 ml, solution injectable en seringue préremplie
A medicinal product containing méthoxy polyéthylène glycol-époétine bêta, registered in France by ROCHE REGISTRATION (ALLEMAGNE), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- MÉTHOXY POLYÉTHYLÈNE GLYCOL-ÉPOÉTINE BÊTA
- Manufacturer
- ROCHE REGISTRATION (ALLEMAGNE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009381514591 seringue(s) préremplie(s) en verre de 0,3 ml avec aiguille(s)EUR 50.95
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Méthoxy polyéthylène glycol-époétine bêta in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandMirceraAbacus Medicine A/S
- United StatesMirceraVifor (International) Inc.
- IcelandMirceraRoche Registration GmbH*
- NetherlandsMircera 100 µg / 0,3 ml, oplossing voor injectie (in voorgevulde spuit)Roche Registration GmbH
- SwedenMIRCERA 100 mikrogram/0,3 ml Injektionsvätska, lösning i förfylld sprutaRoche Registration GmbH
- United KingdomMircera 100micrograms/0.3ml solution for injection pre-filled syringesRoche Products Ltd
- IrelandMircera 100 micrograms/0.3 ml solution for injection in pre-filled syringeRoche Registration GmbH
- SwitzerlandMircera 100 ug / 0.3 ml, Injektionslösung in einer FertigspritzeRoche Pharma (Schweiz) AG
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Mircera
- Liechtenstein · Mircera
- Norway · Mircera
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d91d5dc4-e189-4290-8f0f-0ff1bb44f676 GET /v1/drugs/d91d5dc4-e189-4290-8f0f-0ff1bb44f676?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "63878513",
"date_amm": "2007-07-20",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/07/400",
"substance": "MÉTHOXY POLYÉTHYLÈNE GLYCOL-ÉPOÉTINE BÊTA",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution injectable",
"voies_administration": "intraveineuse;sous-cutanée",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about méthoxy polyéthylène glycol-époétine bêta.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.